Abstract-The increased expression of plasminogen activator inhibitor type-1 (PAI-1) is associated with increased concentrations of fatty acids in blood and may accelerate atherogenesis in diabetes. The present study was designed to define mechanisms by which nonesterified (free) fatty acids (FFAs) augment the expression of PAI- Key Words: Diabetes mellitus Ⅲ PAI-1 Ⅲ free fatty acids Ⅲ Sp1 P lasminogen activator inhibitor type 1 (PAI-1), the primary physiological inhibitor of plasminogen activators, is increased in blood in patients with diabetes mellitus. 1 Altered lipid metabolism is associated with increased concentrations of triglycerides and nonesterified (free) fatty acids (FFAs) in these subjects. 2 We have found that the infusion of glucose and emulsified triglycerides (in combination with heparin to increase FFA concentrations) into healthy human subjects increases the concentration of PAI-1 in blood. 3 Further, the exposure of cells to triglycerides increases elaboration of PAI-1 protein secondary to increased transcription. 4 -6 In previous work, we found that the effect of triglycerides on expression of PAI-1 appears to be mediated, at least in part, by their constituents: FFAs. 7 Both FFAs and their metabolites, particularly long-chain acyl-CoA, have been shown to regulate the expression of genes through binding to or modification of transcription factors. 8 -11 We postulated that the induction of PAI-1 by FFAs is secondary to a direct or an indirect effect of FFAs on the expression and/or activation of a transcription factor or factors that bind to a cis-acting element in the 5Ј flanking region of the PAI-1 gene. The present study was designed to identify the cis-acting element or elements.
P lasminogen activator inhibitor type 1 (PAI-1), the primary physiological inhibitor of plasminogen activators, is increased in blood in patients with diabetes mellitus. 1 Altered lipid metabolism is associated with increased concentrations of triglycerides and nonesterified (free) fatty acids (FFAs) in these subjects. 2 We have found that the infusion of glucose and emulsified triglycerides (in combination with heparin to increase FFA concentrations) into healthy human subjects increases the concentration of PAI-1 in blood. 3 Further, the exposure of cells to triglycerides increases elaboration of PAI-1 protein secondary to increased transcription. 4 -6 In previous work, we found that the effect of triglycerides on expression of PAI-1 appears to be mediated, at least in part, by their constituents: FFAs. 7 Both FFAs and their metabolites, particularly long-chain acyl-CoA, have been shown to regulate the expression of genes through binding to or modification of transcription factors. 8 -11 We postulated that the induction of PAI-1 by FFAs is secondary to a direct or an indirect effect of FFAs on the expression and/or activation of a transcription factor or factors that bind to a cis-acting element in the 5Ј flanking region of the PAI-1 gene. The present study was designed to identify the cis-acting element or elements.
Methods

Cell Culture
Human hepatoma (HepG2) cells were obtained from American Type Culture Collection and grown in minimal essential media (MEM; GIBCO BRL) with 10% NuSerum (GIBCO BRL). Experiments were performed in DMEM with Ham's nutrient mixture F12 (DME-F12; GIBCO BRL).
The sodium salts of FFAs (Sigma Chemical Co) were dissolved in water at 37°C and added dropwise to 1% fatty acid-free bovine serum albumin (FAF-BSA; Sigma Chemical Co) in DME-F12. We determined that 3% BSA in DME-F12 contains 0.45 mmol/L FFAs (Wako NEFA C kits; Biochemical Diagnostics). All solutions were adjusted to pH 7.4 and filtered through a 0.22-m filter.
Eighty percent confluent HepG2 cells were preincubated in serum-free DME-F12 for 4 to 8 hours. Subsequently, cells were exposed to DME-F12 with FAF-BSA, DME-F12 with FAF-BSA to which selected fatty acids were added, or DME-F12 with BSA. Conditioned media were collected after selected intervals and assayed for PAI-1 by ELISA (Tintelize; Biopool). Total cellular RNA was isolated conventionally with TRIzol Reagent (GIBCO BRL). Northern blotting was performed as previously described with 10 g RNA. 12 inserted into the unique KpnI site of the promoter-less luciferase reporter plasmid pGL3-Basic (Promega), and referred to as PAI-LUC 1313. A 927-bp XhoI fragment (from Ϫ853 to ϩ74 in human PAI-1 DNA) was inserted into the XhoI site of pGL3-Basic and referred to as PAI-LUC 853. Polymerase chain reaction was used to amplify a 684-bp fragment that encompassed Ϫ610 to ϩ74 (5Ј primer, 5Ј-cta ggt acc aga cca aga gtc ctc tgt tg-3Ј; 3Ј primer, 5Ј-aat gga tcc gaa ttc agc tgc tgg agg-3Ј). This fragment was inserted into pGL3-Basic and referred to as PAI-LUC 610. A 402-bp HindIII fragment containing Ϫ328 to ϩ74 bp of the PAI-1 gene was inserted into pGL3-Basic and referred to as PAI-LUC 328. A 72-bp ApaI fragment (Ϫ599 to Ϫ528) containing a potential fatty acid response element 14 was deleted from PAI-LUC 1313 to form PAI-LUC 1313Ϫ72. To generate PAI-LUC 328ϩ72, the 72-bp ApaI fragment was inserted upstream of the minimal promoter (PAI-LUC 328) in the sense orientation. The 72ϩpGL3-Promoter was generated by inserting the 72-bp KpnI/XhoI fragment upstream of the simian virus (SV)40 promoter in pGL3-Promoter (Promega).
Transient transfection of HepG2 cells was performed according to the calcium-phosphate precipitation method as previously described. 13 Transfections were performed with 12 g reporter plasmid and 600 ng pRL-cytomegalovirus (CMV), a plasmid with Renilla luciferase gene downstream of the CMV promoter to control for transfection efficiency. Luciferase activity was detected in cell extracts with the Passive Lysis Buffer in the Dual-Luciferase Reporter Assay System (Promega). Luciferase activities were determined with the Dual-Luciferase Reporter Assay with a DLReady luminometer (Turner Designs Instrument).
DNase I footprinting was performed with Ϫ618 to Ϫ487 of the PAI-1 gene in accordance with the Maxam method. 15 Protein extract (100 g) was used in a 50-L reaction that contained 10 mmol/L Tris, pH 7.5, 50 mmol/L NaCl, 1 mmol/L EDTA, 1% Ficoll, and 1 g poly(dI/dC)⅐poly(dI/dC).
Electrophoretic Mobility Shift Assays
Proteins were extracted from HepG2 cells exposed to control media (DME-F12 with 1% FAF-BSA) and to 0.75 mmol/L capric acid in DME-F12 with 1% FAF-BSA according to the freeze-thaw method described by Ladias et al. 16 Oligonucleotides of PAI-1 5Ј flanking DNA and Sp1 consensus sequences 17 that were used in electrophoretic mobility shift assays (EMSAs) were synthesized at Life Technology (GIBCO BRL) and include 29 bp, 5Ј-gcatgccctgtggctgttgggctgggccc-3Ј and 5Ј-gggcccagcccaacagccacagggcatgc-3Ј; 15 bp, 5Ј-tggctgttgggctgg-3Ј and 5Ј-ccagcccaacagcca-3Ј; 9 bp, 5Ј-tggctgttg-3Ј and 5Ј-caacagcca-3Ј; 23 bp, 5Ј-cacgtggctggctgcatgccctg-3Ј and 5Ј-cagggcatgcagccagccacgtg-3Ј; 18 bp, 5Ј-cacgtggctggctgcatg-3Ј and 5Ј-catgcagccagccacgtg-3Ј; 13 bp, 5Ј-cacgtggctggct-3Ј and 5Ј-agccagccacgtg-3Ј; 10 bp, 5Ј-gcatgccctg-3Ј and 5Ј-cagggcatgc-3Ј; C13, 5Ј-tggctgctggctg-3Ј and 5Ј-cagccagcagcca-3Ј; M13, 5Ј-taactgctaactg-3Ј and 5Ј-cagttagcagtta-3Ј; 30 bp, 5Ј-aagtcctagacagacaaaacctagacaatc-3Ј and 5Ј-gattgtctaggttttgtctgtctaggactt-3Ј; Sp1, 5Ј-acaattgggctgggcctaat-3Ј and 5Ј-attaggcccagcccaattgt-3Ј and 5Ј-attcgatcggggcggggcgagc-3Ј and 5Ј-gctcgccccgccccgatcgaat-3Ј (Promega); and 24 bp, 5Ј-tcacagaacatgtctctatcgtaa-3Ј and 5Ј-ttacgatagagagatgttcagtga-3Ј (control). Double-strand oligonucleotides were end-labeled with (␥-32 P)-ATP and T4 polynucleotide kinase. Unincorporated nucleotides were removed with a NucTrap column (Stratagene). EMSAs were performed as previously described. 18 
Statistical Analysis
Results are given as meanϮSEM. Differences between 2 groups were identified with a Student's t test. For multiple groups, 1-way ANOVA and Student-Newman-Keuls tests were used to identify differences. Significance was defined as PϽ0.05.
Results
FFAs and Accumulation of PAI-1 in Conditioned Media
Increased PAI-1 was seen in media conditioned with HepG2 cells after exposure to FFAs. Compared with FAF-BSA, 3%
BSA containing a physiological mixture of FFAs increased 24-hour accumulation of PAI-1 by 2.2Ϯ0.8-fold (nϭ6, PϽ0.01). To confirm that effects with BSA were mediated by FFAs, cells were exposed to selected FFAs, including capric acid, linoleic acid, and lauric acid. Similar increases were seen in the accumulation of PAI-1 in 24-hour-conditioned media (capric acid by 3.0Ϯ0.1-fold; linoleic acid by 2.6Ϯ0.1-fold; and lauric acid by 2.5Ϯ0.2-fold, nϭ6 for each, PϽ0.005). Increases were concentration dependent ( Figure 1 ).
FFAs and Expression of PAI-1 mRNA
Exposure to 0.75 mmol/L capric acid led to a 2Ϯ0.02-fold increase in 3.2-kb PAI-1 mRNA and a 2.8Ϯ0.1-fold increase in 2.2-kb PAI-1 mRNA (nϭ3, PϽ0.001). Maximal increases were seen 16 to 48 hours after exposure.
FFAs and Luciferase Activity
HepG2 cells were transfected with PAI-LUC reporter constructs ( Figure 2) . A 1.7-fold increase in luciferase activity (corrected for transfection efficiency) was seen in extracts from cells transfected with PAI-LUC 1313, 853, or 610 after exposure to 0.75 mmol/L albumin-bound FFAs (nϭ6 for each). Comparable results were seen with capric acid and with 3% BSA binding a physiological mixture of FFAs (fold induction with 3% BSA, 1.36Ϯ0.02 for PAI-LUC 1313 and 1.35Ϯ0.03 for PAI-LUC 610, nϭ6 for each, PϽ0.001).
After the deletion of a 72-bp ApaI fragment (Ϫ599 to Ϫ528, PAI-LUC 1313Ϫ72), neither 3% BSA nor capric acid augmented luciferase activity. FFA-induced increased luciferase activity was seen when the 72-bp segment was inserted upstream of the minimal promoter (PAI-LUC 328ϩ72, 1.43Ϯ0.04-fold increase with 3% BSA, nϭ6, PϽ0.001). Increased FFA-induced luciferase activity was also seen when the 72-bp fragment was inserted upstream of the SV40 promoter in pGL3-Promoter (1.29Ϯ0.01-fold, nϭ8, PϽ0.001). Accordingly, the 72-bp segment, from Ϫ599 to Ϫ528 of the PAI-1 gene, contains the fatty acid response region.
Interaction Between Extracted Proteins and Fatty Acid Response Region
DNase I footprinting was performed with a 130-bp endlabeled fragment spanning Ϫ618 to Ϫ488 in the PAI-1 
Interaction of DNA With Proteins Extracted From HepG2 Cells
One fragment that encompasses the entire footprinted A region, 2 overlapping fragments (29 and 23 bp) that encompass the footprinted A region, and 1 fragment that encompasses the footprinted B region (30 bp) were used for gel mobility shift analysis. These fragments exhibited specific binding to proteins extracted from HepG2 cells (nϭ5 for each; Figure 4) . Results with the fragment that encompasses the entire footprinted region A were similar to those seen with the 29-bp fragment (data not shown). Although 3 DNA/ protein complexes were identified with the selected fragments, only binding of complex I was consistently inhibited with self "cold" (non-labeled). No inhibition was seen when a 24-bp unrelated fragment (100-fold excess) was used as competitor ( Figure 4 ).
FFAs and Binding of Proteins Extracted From HepG2 Cells to Fatty Acid Response Region
Proteins extracted from cells exposed to control conditions (FAF-BSA) and to FFAs were exposed to oligonucleotides in EMSAs. Induction of complex I was seen when the 29-or 30-bp probe was exposed to proteins from cells treated with FFAs. Increased binding was seen 5 to 120 minutes after exposure to FFAs (nϭ3 for each).
Identification of Fatty Acid Response Element
DNA sequence analysis of the fatty acid responsive region identified 4 repeats of the sequence 5Ј-TG(G/C) 1-2 CTG-3Ј in the 23-and 29-bp fragments. The EMSAs demonstrated that the fatty acid responsive element is common to the 29-and 23-bp fragments. Progressively smaller components of the 29-and 23-bp fragments were used to delineate further the fatty acid response element. Complex I was seen with each fragment, including those with a single copy of the implicated fatty acid response element ( Figure 5 ). In addition, EMSAs were performed with a 13-bp oligonucleotide that contained the sequence 5Ј-TGGCTG C TGGCTG-3Ј. This oligonucleotide contains 2 repeats of the implicated fatty acid response element with 1 spacer (C). The same shifted pattern was seen when the oligonucleotide was incubated with proteins extracted from HepG2 cells. Mutation of "GG" to "AA" abolished the binding when the probe 5Ј-TAACTG C TAACTG-3Ј was used in the EMSAs.
Involvement of a Transcription Factor That Binds to Sp1 Consensus Sites
Footprinted region A contains 4 repeats of the implicated fatty acid response element. The sequence is similar to the Sp1 binding sequence (T/G)(G/A)GGC(T/G)G(G/A)(G/ A)(C/T).
In addition, footprinted region B contains a 10-bp segment that has 70% identity with the Sp1 consensus site. Thus, EMSAs were performed with Sp1 consensus oligonucleotides and demonstrated a DNA-protein complex with an electrophoretic mobility pattern similar to that seen with complex I (Figure 6 ). Binding of extracted protein to complex I with the 29-or 23-bp fragment was inhibited with a 100-fold molar excess of unlabeled Sp1 consensus DNA ( Figure 6 ). Inhibition was seen also when extracted proteins were exposed to unlabeled 29-or 23-bp fragments before exposure to radiolabeled Sp1 consensus oligonucleotides.
The 30-bp fragment inhibited binding of proteins to complex I when competition EMSAs were performed with the 29-bp, 23-bp, or Sp1 consensus ( Figure 6 ). Similarly, unlabeled 29-bp, 23-bp, and Sp1 consensus oligonucleotides inhibited the binding of proteins to the radiolabeled 30-bp fragment. Thus, the results of the competition EMSAs suggest that a protein that can bind to Sp1 consensus DNA increases transcription of the PAI-1 gene after exposure of the HepG2 cells to FFAs.
Discussion
Patients with type II diabetes have increased concentrations of FFAs and PAI-1 in their blood. 1, 19 The increased expression of PAI-1 is likely to accelerate atherogenesis and to contribute to an increased incidence of acute myocardial infarction. 20 -22 Increased PAI-1 in blood predisposes to more persistent and more exuberant thrombosis by impairing the fibrinolytic response. Accordingly, vessel walls may be exposed to increased concentrations of clot-associated mitogens for prolonged intervals. Identification of the mechanisms responsible for increased expression of PAI-1 should facilitate the development of novel therapies with the aim of retarding the progression of atherosclerosis and preventing myocardial infarction.
In the present study, we found that a physiological mixture of fatty acids associated with BSA as well as 2 medium-chain length fatty acids (capric acid and lauric acid) and a longchain polyunsaturated fatty acid (linoleic acid) increase the expression of PAI-1 in HepG2 cells. Our results are consistent with those of others that demonstrate increased expression of PAI-1 by FFAs of varying chain length and saturation. 4, 23, 24 Thus, the effect of fatty acids on the expression of PAI-1 appears to be related to the prevailing concentration of diverse FFAs rather than to the concentration of a specific fatty acid.
We used chimeric genes that contain firefly luciferase as a reporter downstream of selected segments of 5Ј flanking DNA from the human PAI-1 gene to identify the mechanism by which fatty acids augment the expression of PAI-1. Deletion analysis of the PAI-1 promoter region indicated that the fatty acid response region is located between Ϫ599 and Ϫ528 in the PAI-1 5Ј flanking region. The implicated fatty acid response element is distinct from the VLDL response element identified by Erikssen et al. 6 These results suggest that FFAs augment the expression of PAI-1 independent of effects mediated by triglycerides or lipoproteins. DNA sequence analysis demonstrated that the implicated fatty acid response sequence was repeated 4 times in the footprinted region A. The footprinted region B contains a sequence "TGTCTG" in the complementary strand that is 83% identical to the implicated fatty acid response element. Sp1 recognition sequences are functional in either orientation 17 Thus, despite the asymmetry of Sp1-binding sites, competition between the 30-bp fragment and the 29-or 23-bp fragment would be expected. Further, the increased binding of proteins to the fatty acid response element seen within 5 minutes after exposure of the cells to FFAs suggests activation rather than induction of a transcription factor. Accordingly, increased expression of PAI-1 after exposure of the HepG2 cells to FFAs is secondary to activation of a transcription factor that binds to a repeated element in the 5Ј flanking region of the PAI-1 gene.
Three fatty acid response regions have been described previously. 10, 25, 26 A cis-linked fatty acid response element was localized to a 140-bp (Ϫ80 to Ϫ220) region within the S14 proximal promoter. 10, 25, 26 In the pyruvate kinase gene, a fatty acid response region was identified that overlaps the glucose/insulin response element. These results suggest that fatty acids inhibit the pyruvate kinase transcription by interfering with glucose and insulin induction of the gene. 25 Specific binding of trans-acting proteins to the response regions was not defined in these studies. The third fatty acid responsive region was identified in the stearoyl-CoA desaturase gene 1 (SCD 1). Proteins from HepG2 cells and 3T3-L1 cells have been shown to bind specifically to a 60-bp region in the SCD1 promoter. 26 Thus, the present results constitute the first report of a Sp1 consensus site that mediates the effects of fatty acids.
Sp1-like proteins are a family of proteins that contain 3 highly conserved C-terminal zinc finger domains and bind to GC-rich sequences. 17, 27 Consistent with our observation, Sp1-responsive promoters usually contain multiple recognition sites, although a single binding site appears to be sufficient for a promoter to be stimulated by Sp1. 17 Previous studies have demonstrated that Sp1 sites contribute to transcriptional activation of the rat PAI-1 gene. 28 Proteins extracted from HTC rat hepatoma cells bind to Sp1 and CTF/NF-1-like binding sites in the rat PAI-1 regulatory region. 28 An Sp1-binding site identified in the rat PAI-1 gene corresponds to the binding sites identified in footprint A in the present study. The activation of Sp1 in a different region of the PAI-1 gene has been implicated in glucose-mediated increased expression of PAI-1. 29 In studies with rat aortic smooth muscle cells, glucose has been shown to release a transcriptional repressor from Sp1 complexes. By contrast, we found that FFAs activate a transcription factor that binds to Sp1 consensus sites. Thus, the increased expression of PAI-1 seen in subjects with diabetes appears to be secondary, at least in part, to increased transcription of PAI-1 induced by Sp1-binding sites and mediated by increased concentrations of both glucose and FFAs.
In summary, we have found that fatty acids augment the expression of PAI-1 in a human hepatoma cell line (HepG2). FFAs activate a transcription factor that binds to the sequence 5Ј-TG(G/C) 1-2 CTG-3Ј in the 5Ј flanking DNA of the human PAI-1 gene. This sequence is nearly identical to the DNAbinding site for Sp1. Further characterization of the transcrip- In lane 6, a probe (C13) containing 2 copies of the implicated fatty acid response element was used. Lane 7 shows results with a probe (M13) in which the "GG" (from C13 used in lane 6) has been changed to "AA." Probes were exposed to extracted proteins from HepG2 cells exposed to 0.75 mmol/L capric acid. These results demonstrate that extracted proteins bind to the sequence 5Ј-TG(G/C) 1-2 CTG-3Ј. Figure 6 . An Sp1 consensus oligonucleotide was used in competition EMSAs. All probes were incubated with proteins extracted from HepG2 cells exposed to 0.75 mmol/L capric acid (results have been confirmed in Ն3 experiments). In lanes 1 through 3, radiolabeled 29-bp probe was used; lanes 4 and 5, radiolabeled 23-bp probe, lanes 6 to 10, radiolabeled Sp1 consensus DNA probe; and lanes 11 and 12, radiolabeled 30-bp probe. Lanes 1, 4, 6, 9, and 11 show results without competition. In lanes 2 and 3, the cell extract was incubated with 20-(lane 2) and 100-fold (lane 3) excess of unlabeled Sp1 consensus DNA before exposure to the radiolabeled probe. In lanes 5 and 12, the protein extract was incubated with 100-fold excess of unlabeled Sp1 consensus DNA before incubation with the radiolabeled probe. In lanes 7, 8, and 10, the cell extract was exposed to 100-fold excess of unlabeled 29-, 23-, and 30-bp probe before exposure to the radiolabeled Sp1 oligonucleotide. Thus, the Sp1 oligonucleotide inhibits binding of extracted protein to the 29-, 23-, and 30-bp probes.
tion factor responsible for FFA-induced augmented expression of PAI-1 and its interaction with other transcription factors may provide a therapeutic target for modification of the expression of PAI-1 in diabetic subjects.
